Eli Lilly hikes sales outlook, as CEO says there's room for 'dramatic' obesity market expansion
Eli Lilly reported that sales of obesity drug Zepbound and diabetes treatment Mounjaro surged again in the third quarter.
Taƙaitaccen labari
Eli Lilly reported that sales of obesity drug Zepbound and diabetes treatment Mounjaro surged again in the third quarter.
Bi sabbin labarai daga amintattun mawallafa tare da taƙaitaccen bayani. Buɗe mahaɗin tushe na asali don cikakken bayani.